DrugPatentWatch Database Preview
Investigational Drug Information for Serlopitant
Email this page to a colleague
What is the development status for investigational drug Serlopitant?
Serlopitant is an investigational drug.
There have been 12 clinical trials for Serlopitant.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 2nd 2018.
The most common disease conditions in clinical trials are Pruritus, Prurigo, and Neurodermatitis. The leading clinical trial sponsors are Menlo Therapeutics Inc., Vyne Therapeutics Inc., and Epidermolysis Bullosa Research Partnership.
There are twenty-five US patents protecting this investigational drug and ninety-nine international patents.
Summary for Serlopitant
| US Patents | 25 |
| International Patents | 99 |
| US Patent Applications | 93 |
| WIPO Patent Applications | 77 |
| Japanese Patent Applications | 9 |
| Clinical Trial Progress | Phase 3 (2018-05-02) |
| Vendors | 16 |
Recent Clinical Trials for Serlopitant
| Title | Sponsor | Phase |
|---|---|---|
| A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa | Epidermolysis Bullosa Research Partnership | Phase 2 |
| A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa | Menlo Therapeutics | Phase 2 |
| A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa | Stanford University | Phase 2 |
Clinical Trial Summary for Serlopitant
Top disease conditions for Serlopitant
Top clinical trial sponsors for Serlopitant
US Patents for Serlopitant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Serlopitant | ⤷ Try it Free | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try it Free |
| Serlopitant | ⤷ Try it Free | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | ⤷ Try it Free |
| Serlopitant | ⤷ Try it Free | ⤷ Try it Free | ||
| Serlopitant | ⤷ Try it Free | Use of NK-1 receptor antagonist serlopitant in pruritus | Menlo Therapeutics Inc. (Redwood, CA) | ⤷ Try it Free |
| Serlopitant | ⤷ Try it Free | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | ⤷ Try it Free |
| Serlopitant | ⤷ Try it Free | Use of NK-1 receptor antagonist serlopitant in pruritus | MENLO THERAPEUTICS INC. (Redwood City, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Serlopitant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Serlopitant | Australia | AU2017261372 | 2036-05-05 | ⤷ Try it Free |
| Serlopitant | Canada | CA3023278 | 2036-05-05 | ⤷ Try it Free |
| Serlopitant | China | CN107847398 | 2036-05-05 | ⤷ Try it Free |
| Serlopitant | European Patent Office | EP3452003 | 2036-05-05 | ⤷ Try it Free |
| Serlopitant | Hong Kong | HK1249728 | 2036-05-05 | ⤷ Try it Free |
| Serlopitant | Japan | JP2019520866 | 2036-05-05 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
